BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14502382)

  • 21. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]).
    Lim P; Moutereau S; Simon T; Gallet R; Probst V; Ferrieres J; Gueret P; Danchin N
    Am J Cardiol; 2013 Jan; 111(1):31-7. PubMed ID: 23062316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation.
    Souza JR; Oliveira RT; Blotta MH; Coelho OR
    Arq Bras Cardiol; 2008 Feb; 90(2):86-90. PubMed ID: 18392379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes.
    Çoner A; Aydınalp A; Müderrisoğlu H
    Endocr Metab Immune Disord Drug Targets; 2020; 20(1):96-103. PubMed ID: 30961517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes.
    Oltrona L; Ottani F; Galvani M;
    Am Heart J; 2004 Sep; 148(3):405-15. PubMed ID: 15389226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Coronary biomarkers and long-term clinical outcome in acute coronary syndrome without ST segment elevation].
    Baeza V R; Corbalán H R; Castro G P; Acevedo B M; Quiroga G T; Viviani G P
    Rev Med Chil; 2005 Nov; 133(11):1285-93. PubMed ID: 16446851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of inflammatory biomarkers between diabetic and non-diabetic patients with unstable angina.
    Huoya Mde O; Penalva RA; Alves SR; Feitosa GS; Gadelha S; Ladeia AM
    Arq Bras Cardiol; 2009 Apr; 92(4):283-9. PubMed ID: 19565136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].
    Namal E; Sener N; Ulaş T; Akçalı Z; Oztekin E; Borlu F
    Anadolu Kardiyol Derg; 2011 Dec; 11(8):703-10. PubMed ID: 22088858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between biochemical markers and coronary angiography in patients with non-ST elevation acute coronary syndromes].
    Magalhães CK; Siqueira Filho AG; Amino JG; Nolasco M
    Arq Bras Cardiol; 2006 Mar; 86(3):223-31. PubMed ID: 16612451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High-affinity C-reactive protein as inflammatory marker].
    Ramírez Velázquez C; Martínez Juárez G; Lozano Nuevo J; Olvera Medel A; Higuera Acuña L; García Quijano E; Guido Bayardo R; Castrejón Vázquez I
    Rev Alerg Mex; 2007; 54(1):7-13. PubMed ID: 17542249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein increase in unstable coronary disease cause or effect?
    De Servi S; Mariani M; Mariani G; Mazzone A
    J Am Coll Cardiol; 2005 Oct; 46(8):1496-502. PubMed ID: 16226174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction.
    Hashimoto T; Ishii J; Kitagawa F; Yamada S; Hattori K; Okumura M; Naruse H; Motoyama S; Matsui S; Tanaka I; Izawa H; Maruyama I; Nomura M; Ozaki Y
    Atherosclerosis; 2012 Apr; 221(2):490-5. PubMed ID: 22369934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
    Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
    Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
    Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes.
    Stefanadis C; Diamantopoulos L; Dernellis J; Economou E; Tsiamis E; Toutouzas K; Vlachopoulos C; Toutouzas P
    J Mol Cell Cardiol; 2000 Jan; 32(1):43-52. PubMed ID: 10652189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
    Sanchez PL; Morinigo JL; Pabon P; Martin F; Piedra I; Palacios IF; Martin-Luengo C
    Heart; 2004 Mar; 90(3):264-9. PubMed ID: 14966041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event--temporal trends].
    Mouco OM; Nicolau JC; Souza Tda R; Maia LN; Ramires JA
    Arq Bras Cardiol; 2006 Jul; 87(1):28-36. PubMed ID: 16906267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction.
    Matsui S; Ishii J; Kitagawa F; Kuno A; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Tanaka I; Nomura M; Hishida H; Ozaki Y
    Atherosclerosis; 2010 May; 210(1):220-5. PubMed ID: 19945702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.